{"id":"https://openalex.org/W1990275483","doi":"https://doi.org/10.1097/wad.0b013e31826d597a","title":"Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease","display_name":"Evaluation of Plasma Proteomic Data for Alzheimer Disease State Classification and for the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease","alternate_titles":[],"publication_year":2012,"publication_date":"2012-09-30","ids":{"openalex":"https://openalex.org/W1990275483","doi":"https://doi.org/10.1097/wad.0b013e31826d597a","mag":"1990275483","pmid":"https://pubmed.ncbi.nlm.nih.gov/23023094"},"language":"en","primary_location":{"id":"doi:10.1097/wad.0b013e31826d597a","doi":"https://doi.org/10.1097/wad.0b013e31826d597a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wad.0b013e31826d597a","pdf_url":null,"source":{"id":"https://openalex.org/S107889856","display_name":"Alzheimer Disease & Associated Disorders","issn_l":"0893-0341","issn":["0893-0341","1546-4156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer Disease &amp; Associated Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990275483"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060781519","display_name":"Daniel A. Llano","orcid":"https://orcid.org/0000-0003-0933-1837","observed_orcids":["https://orcid.org/0000-0003-0933-1837"]},"institutions":[{"id":"https://openalex.org/I157725225","display_name":"University of Illinois Urbana-Champaign","ror":"https://ror.org/047426m28","country_code":"US","type":"education","lineage":["https://openalex.org/I157725225"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daniel A. Llano","raw_affiliation_strings":["Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign 61801, USA. d-llano@uiuc.edu","Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign 61801, USA. d-llano@uiuc.edu","institution_ids":["https://openalex.org/I157725225"]},{"raw_affiliation_string":"Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign","institution_ids":["https://openalex.org/I157725225"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041938256","display_name":"Viswanath Devanarayan","orcid":"https://orcid.org/0000-0003-2059-9252","observed_orcids":["https://orcid.org/0000-0003-2059-9252"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Viswanath Devanarayan","raw_affiliation_strings":["Exploratory Statistics, Global Pharmaceutical R&D, Abbott Laboratories, Abbott Park, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exploratory Statistics, Global Pharmaceutical R&D, Abbott Laboratories, Abbott Park, IL","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103413243","display_name":"Adam J. Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800718396","display_name":"Foundation for the National Institutes of Health","ror":"https://ror.org/00k86s890","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800718396"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adam J. Simon","raw_affiliation_strings":["AJ Simon Enterprises LLC, Yardley, PA","Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, www.alzheimerjournal.com","The Foundation for the National Institutes of Health (http://www.fnih.org) coordinates the private sector participation of the $60 million ADNI public-private partnership that was begun by the National Institute on Aging (NIA) and supported by the National Institutes of Health. To date, >$27 million has been provided to the Foundation for NIH by Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson & Johnson, Eli Lilly and Co., Merck and Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche, Schering-Plough, Synarc Inc., and Wyeth, as well as nonprofit partners the Alzheimer Association and the Institute for the Study of Aging"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AJ Simon Enterprises LLC, Yardley, PA","institution_ids":[]},{"raw_affiliation_string":"Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website, www.alzheimerjournal.com","institution_ids":[]},{"raw_affiliation_string":"The Foundation for the National Institutes of Health (http://www.fnih.org) coordinates the private sector participation of the $60 million ADNI public-private partnership that was begun by the National Institute on Aging (NIA) and supported by the National Institutes of Health. To date, >$27 million has been provided to the Foundation for NIH by Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson & Johnson, Eli Lilly and Co., Merck and Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche, Schering-Plough, Synarc Inc., and Wyeth, as well as nonprofit partners the Alzheimer Association and the Institute for the Study of Aging","institution_ids":["https://openalex.org/I2800718396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060781519"],"corresponding_institution_ids":["https://openalex.org/I157725225"],"apc_list":null,"apc_paid":null,"fwci":3.5419,"has_fulltext":false,"cited_by_count":78,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92199899,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"27","issue":"3","first_page":"233","last_page":"243"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13077","display_name":"Cancer-related cognitive impairment studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/mild-cognitive-impairment","display_name":"mild cognitive impairment","score":0.9860000014305115},{"id":"https://openalex.org/keywords/plasma-proteomics","display_name":"plasma proteomics","score":0.800000011920929},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.7860000133514404},{"id":"https://openalex.org/keywords/disease-state-classification","display_name":"disease state classification","score":0.7390000224113464},{"id":"https://openalex.org/keywords/proteomic-signatures","display_name":"proteomic signatures","score":0.8740000128746033},{"id":"https://openalex.org/keywords/apolipoprotein-e","display_name":"apolipoprotein E","score":0.9110000133514404},{"id":"https://openalex.org/keywords/apolipoprotein-a-ii","display_name":"apolipoprotein A-II","score":0.9909999966621399},{"id":"https://openalex.org/keywords/aspartate-aminotransferase","display_name":"aspartate aminotransferase","score":0.9179999828338623},{"id":"https://openalex.org/keywords/alpha-1-microglobulin","display_name":"alpha1-microglobulin","score":0.9660000205039978},{"id":"https://openalex.org/keywords/brain-natriuretic-peptide","display_name":"brain natriuretic peptide","score":0.9900000095367432}],"concepts":[{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.6447014808654785},{"id":"https://openalex.org/C57089818","wikidata":"https://www.wikidata.org/wiki/Q424728","display_name":"Apolipoprotein E","level":3,"score":0.5350609421730042},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5322864651679993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4926298260688782},{"id":"https://openalex.org/C68026918","wikidata":"https://www.wikidata.org/wiki/Q1970256","display_name":"Senile plaques","level":4,"score":0.4798718988895416},{"id":"https://openalex.org/C2778373026","wikidata":"https://www.wikidata.org/wiki/Q4738819","display_name":"Alzheimer's Disease Neuroimaging Initiative","level":4,"score":0.47859832644462585},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4066939949989319},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3909912109375},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35254502296447754},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3232409656047821}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040901","descriptor_name":"Proteomics","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D060825","descriptor_name":"Cognitive Dysfunction","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/wad.0b013e31826d597a","doi":"https://doi.org/10.1097/wad.0b013e31826d597a","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wad.0b013e31826d597a","pdf_url":null,"source":{"id":"https://openalex.org/S107889856","display_name":"Alzheimer Disease & Associated Disorders","issn_l":"0893-0341","issn":["0893-0341","1546-4156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer Disease &amp; Associated Disorders","raw_type":"journal-article"},{"id":"pmid:23023094","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23023094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer disease and associated disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5707695498","display_name":"Alzheimer's Disease Neuroimaging Initiative","funder_award_id":"U01AG024904","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W273955616","https://openalex.org/W1484920908","https://openalex.org/W1530928952","https://openalex.org/W1541511714","https://openalex.org/W1629460796","https://openalex.org/W1968440938","https://openalex.org/W1969905245","https://openalex.org/W1972693293","https://openalex.org/W1974604086","https://openalex.org/W1992901525","https://openalex.org/W1994810477","https://openalex.org/W1994994999","https://openalex.org/W2004531476","https://openalex.org/W2006651597","https://openalex.org/W2010556599","https://openalex.org/W2015036079","https://openalex.org/W2017260345","https://openalex.org/W2017779103","https://openalex.org/W2021560851","https://openalex.org/W2022019816","https://openalex.org/W2028480234","https://openalex.org/W2041546150","https://openalex.org/W2047219385","https://openalex.org/W2049131636","https://openalex.org/W2050607653","https://openalex.org/W2052530454","https://openalex.org/W2052909311","https://openalex.org/W2055925643","https://openalex.org/W2057367433","https://openalex.org/W2065184319","https://openalex.org/W2071397884","https://openalex.org/W2073813663","https://openalex.org/W2078052928","https://openalex.org/W2081140305","https://openalex.org/W2086104636","https://openalex.org/W2092862747","https://openalex.org/W2096369813","https://openalex.org/W2097903748","https://openalex.org/W2099570666","https://openalex.org/W2101077392","https://openalex.org/W2105778736","https://openalex.org/W2106116591","https://openalex.org/W2107956883","https://openalex.org/W2109103446","https://openalex.org/W2115017507","https://openalex.org/W2116028889","https://openalex.org/W2117521122","https://openalex.org/W2117661338","https://openalex.org/W2131215891","https://openalex.org/W2136990837","https://openalex.org/W2151409655","https://openalex.org/W2156220037","https://openalex.org/W2157110881","https://openalex.org/W2159122349","https://openalex.org/W2171537806","https://openalex.org/W2323303817","https://openalex.org/W2911964244","https://openalex.org/W2912934387"],"related_works":["https://openalex.org/W1971928023","https://openalex.org/W4415173639","https://openalex.org/W2027980574","https://openalex.org/W4406197009","https://openalex.org/W4406209870","https://openalex.org/W2105181416","https://openalex.org/W4390199396","https://openalex.org/W7201856326","https://openalex.org/W4281789187"],"abstract_inverted_index":{"Previous":[0],"studies":[1],"that":[2,90,167],"have":[3,18,31],"examined":[4],"the":[5,25,72,128,189],"potential":[6],"for":[7,14],"plasma":[8,47,172],"markers":[9],"to":[10,33,87,103,109,135,149,152,157,160,179,188,198],"serve":[11],"as":[12],"biomarkers":[13],"Alzheimer":[15],"disease":[16],"(AD)":[17],"studied":[19],"single":[20],"analytes":[21,48,106,173],"and":[22,27,30,98,122,140],"focused":[23],"on":[24],"amyloid-\u03b2":[26],"\u03c4":[28],"isoforms":[29],"failed":[32],"yield":[34],"conclusive":[35],"results.":[36],"In":[37],"this":[38],"study,":[39],"we":[40],"performed":[41],"a":[42,138,168],"multivariate":[43],"analysis":[44],"of":[45,127,146,171,191],"146":[46],"(the":[49],"Human":[50],"DiscoveryMAP":[51],"v":[52],"1.0":[53],"from":[54,71,93,101,133,182],"Rules-Based":[55],"Medicine)":[56],"in":[57],"527":[58],"subjects":[59,70],"with":[60,96],"AD,":[61,192],"mild":[62],"cognitive":[63],"impairment":[64],"(MCI),":[65],"or":[66],"cognitively":[67],"normal":[68],"elderly":[69],"Alzheimer's":[73],"Disease":[74],"Neuroimaging":[75],"Initiative":[76],"database.":[77],"We":[78],"identified":[79],"4":[80,111],"different":[81],"proteomic":[82],"signatures,":[83],"each":[84],"using":[85],"5":[86],"14":[88],"analytes,":[89,147],"differentiate":[91,180],"AD":[92,136,153,181,199],"control":[94],"patients":[95],"sensitivity":[97],"specificity":[99],"ranging":[100],"74%":[102],"85%.":[104],"Five":[105],"were":[107],"common":[108],"all":[110],"signatures:":[112],"apolipoprotein":[113,115],"A-II,":[114],"E,":[116],"serum":[117],"glutamic":[118],"oxaloacetic":[119],"transaminase,":[120],"\u03b1-1-microglobulin,":[121],"brain":[123],"natriuretic":[124],"peptide.":[125],"None":[126],"signatures":[129],"adequately":[130,195],"predicted":[131],"progression":[132],"MCI":[134,151,197],"over":[137],"12-":[139],"24-month":[141],"period.":[142],"A":[143],"new":[144],"panel":[145,170],"optimized":[148],"predict":[150,196],"conversion,":[154],"was":[155],"able":[156],"provide":[158,175,185],"55%":[159],"60%":[161],"predictive":[162],"accuracy.":[163],"These":[164],"data":[165],"suggest":[166],"simple":[169],"may":[174,184],"an":[176],"adjunctive":[177],"tool":[178],"controls,":[183],"mechanistic":[186],"insights":[187],"etiology":[190],"but":[193],"cannot":[194],"conversion.":[200]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990275483","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":8},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
